Palanca A et al, Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes
Over an average follow-up of nearly seven years, the results were striking: for patients whose diabetes was diagnosed within the last 10 years, bariatric surgery slashed the risk of death by 62% compared to GLP-1 drugs (hazard ratio 0.38, 95% CI 0.25-0.58)
Changes in Fat Distribution Research suggests HRT may help prevent abdominal fat gain, supporting metabolic health
Overview of Semaglutide GLP-1 receptor agonists work by affecting hormones that control feelings of fullness, leading to improved satiety and decreased appetite
Liraglutide (Victoza, Saxenda): The SmPC similarly specifies refrigerated storage at 2C to 8C before first use, with in-use stability guidance